Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Breast Cancer Research : BCR|May 14, 2010
Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cellsLuisa Paris, Serena Cecchetti, Francesca Spadaro, et al.
Frontiers in Oncology|August 18, 2016
Activation of Phosphatidylcholine-Specific Phospholipase C in Breast and Ovarian Cancer: Impact on MRS-Detected Choline Metabolic Profile and Perspectives for Targeted TherapyFranca Podo, Luisa Paris, Serena Cecchetti, et al.
Frontiers in Molecular Biosciences|June 8, 2026
NMR metabolomics assessment of neural commitment of human dental pulp-derived stem cellsMattea Chirico, Maria Elena Pisanu, Emanuela Mari, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 1, 2022
AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanismAlessandra Vitaliti, Ilenia Roccatani, Egidio Iorio, et al.
Oncotarget|August 28, 2016
Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transitionNadia Lobello, Flavia Biamonte, Maria Elena Pisanu, et al.
Journal of Translational Medicine|July 30, 2013
Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodiesLuigi Fattore, Emanuele Marra, Maria Elena Pisanu, et al.
Cancers|June 24, 2022
MALAT1 as a Regulator of the Androgen-Dependent Choline Kinase A Gene in the Metabolic Rewiring of Prostate CancerSara De Martino, Egidio Iorio, Chiara Cencioni, et al.
Cancer Research|February 25, 2010
Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cellsEgidio Iorio, Alessandro Ricci, Marina Bagnoli, et al.
Frontiers in Cell and Developmental Biology|November 29, 2023
Lipid rafts mediate multilineage differentiation of human dental pulp-derived stem cells (DPSCs)Francesca Santilli, Jessica Fabrizi, Stefano Martellucci, et al.
Frontiers in Oncology|February 22, 2021
Targeting Lactate Metabolism by Inhibiting MCT1 or MCT4 Impairs Leukemic Cell Proliferation, Induces Two Different Related Death-Pathways and Increases Chemotherapeutic Sensitivity of Acute Myeloid Leukemia CellsErnestina Saulle, Isabella Spinello, Maria Teresa Quaranta, et al.
Pageof 4